Search
for
Sort by
Research 481–510 of 1000+
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- MANAGEMENT OF INDRALUPTA- A CASE REPORT
- Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study
- 812 Multi-view light sheet florescence microscopy (LSFM) for imaging cellular self-assembly in spheroids of human hair follicle dermal papilla cells and keratinocytes
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- 1323 The effects of 3-OH of kaempferol on interfollicular epidermal stem cell fate
- 1324 Impairment of hair-inducing capacity of 3D-cultured human dermal papilla cells by the ablation of STAT5
- 1327 Effect of ginsenoside Rd on dermal epidermal junction in fibroblast
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Complementary evolution of coding and noncoding sequence underlies mammalian hairlessness
- Mechanism of PPARα agonist in alopecia areata
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040